|
Monday 14th February 2011 |
Text too small? |
Pharmacybrands Group is to buy the shares in Radius Pharmacy for $17.1 million, with an assumption of debt of $18 million, subject to net asset and other adjustments.
Pharmacybrands today said the agreement was conditional on the approval of its shareholders, who were expected to meet in late March, and completion of finance arrangements.
Radius Pharmacy holds interests in 34 pharmacies and has annual revenue around $86 million.
Pharmacybrands said Radius Pharmacy would be a strong fit with its existing business, strengthening its ability to invest in systems and other resources to enhance the services to pharmacies operating under its brands.
Retail competition was primarily from other channels and the company must invest in the tools and developing the skills to compete effectively, at the same time as investing in new service opportunities in primary care, Pharmacybrands chief executive Alan Wham said.
NZPA
No comments yet
PYS - PaySauce to announce F26 full year results on 27 May 2026
PEB - Draft LCD Proposes Medicare Coverage for Triage and Triage
MEL - Meridian Energy monthly operating report for April 2026
FBU - Sale of South Australian property
AIR - Air New Zealand market update
May 14th Morning Report
PEB - Pacific Edge Placement Increased to NZ$25.4 Million
Radius Care Reports Earnings Growth and 50% Higher Dividend
May 13th Morning Report
Pacific Edge launches capital raise of NZ$24 million